What does a drop in E1G (Estrogen 1 Glucuronide) to 110 followed by a rise to 128.4, with sustained PdG (Progesterone glucuronide) levels of 20, indicate at 11 and 12 days past the initial LH (Luteinizing Hormone) surge in a patient attempting to conceive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Pattern Interpretation: Post-LH Surge E1G and PdG Levels

Direct Answer

Your hormone pattern shows a normal post-ovulatory luteal phase with the expected mid-luteal estrogen rise, confirming successful ovulation and adequate corpus luteum function. 1, 2

Understanding Your Hormone Values

PdG (Progesterone) Levels

  • Your sustained PdG of 20 μg/mL at both 11 and 12 days post-LH surge confirms ovulation occurred. 1, 3
  • The threshold for ovulation confirmation is 5 μg/mL, and your level of 20 μg/mL indicates robust luteal function. 1, 3
  • After ovulation, the corpus luteum produces progesterone, which rises 24-36 hours post-ovulation and should remain elevated throughout the luteal phase. 4, 3
  • Stable PdG levels at this range (days 11-12 post-LH surge) are physiologically normal and expected during the mid-luteal phase. 5, 6

E1G (Estrogen) Pattern

  • The initial drop to 110 followed by a rise to 128.4 represents the normal biphasic estrogen pattern of the luteal phase. 2, 5
  • After ovulation, estrogen initially decreases as the LH surge induces marked reduction in estrogen production approximately 12 hours prior to ovulation. 4
  • E1G levels rise again during the mid-luteal phase (approximately 7-10 days post-ovulation), reaching levels 2-3 times higher than early follicular baseline. 2
  • Your timing (11-12 days post-LH surge) corresponds precisely to when this mid-luteal estrogen rise should occur. 2, 5

Clinical Significance for Conception

Positive Indicators

  • Both hormones demonstrate a healthy, ovulatory cycle with adequate corpus luteum function. 1, 5
  • The corpus luteum secretes both progesterone and estradiol, reaching peak secretion 6-7 days after ovulation, which aligns with your timeline. 5
  • Elevated progesterone and estrogen together during the mid-luteal phase create optimal conditions for endometrial receptivity and potential implantation. 5, 6

Expected Progression

  • If conception occurred, the corpus luteum will be maintained by hCG from the trophoblast starting 8 days after conception, preventing luteal regression. 5
  • If conception did not occur, progesterone and estrogen will decline as the corpus luteum undergoes passive regression, triggering menstruation. 5
  • The fertile window was 5 days before to the day of ovulation; intercourse during this period maximizes conception probability. 5

Important Caveats

  • Individual cycle length affects timing—these interpretations assume your typical cycle length and ovulation timing. 2, 7
  • Women with shorter cycles (25 days) ovulate earlier, while longer cycles have later ovulation, shifting all post-ovulatory timing accordingly. 2
  • Continue monitoring—if menstruation does not occur within the expected timeframe (typically 12-16 days post-ovulation), pregnancy testing is indicated. 8, 1

References

Guideline

Day 21 Progesterone Level as an Indicator of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Menstrual Cycle Physiology and Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ovulation detection in the human.

Clinical reproduction and fertility, 1982

Research

The normal menstrual cycle in women.

Animal reproduction science, 2011

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Can a woman with a regular menstrual cycle and no underlying medical conditions, such as polycystic ovary syndrome (PCOS) or thyroid disorders, ovulate immediately after her period?
What ovarian phase is a 25-year-old female (Gravida 2, Para 2) in, given her last menstrual period (LMP) was on February 16, 2024, and she presented on an unspecified date with complaints of vaginal discharge?
At what ovarian phase is a 25-year-old gravida 2, para 2 (G2P2) woman during her consultation, given that her last menstrual period (LMP) was on February 16, 2024?
Are menstrual cycle lengths of 47, 38, and 40 days concerning?
What is the best course of treatment for a 25-year-old woman with oligomenorrhea (infrequent menstrual periods) and irregular menstrual cycles ranging from 33 to 45 days?
What is the best approach to manage constipation in a toddler currently being treated with lactulose and Colace (docusate)?
What is the most likely cause of elevated liver enzymes (alanine transaminase (ALT) greater than aspartate transaminase (AST)) and hyperferritinemia in a young male alcoholic and smoker with normal alkaline phosphatase (ALP) levels?
What are the appropriate management and treatment options for a patient experiencing vertigo?
What are the differences in diagnosis, treatment, and management of Subarachnoid Hemorrhage (SAH) in adults, caput succedaneum, and cephalohematoma in newborns?
Are GLP-1 (Glucagon-Like Peptide-1) analogues, such as liraglutide (Victoza) or semaglutide (Ozempic), safe for patients with hyperthyroidism?
A patient with RUQ pain, jaundice, hyperbilirubinemia, leukocytosis, and a dilated common bile duct with multiple gallstones, what is the most likely diagnosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.